Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

Publication | Closed Access

DOI

271

Citations

References

2011

Year

Akshay S. Desai, Eldrin F. Lewis, Rebecca Li, Scott D. Solomon, Susan F. Assmann, Robin Boineau, Nadine Clausell, Rafael Díaz, Jerome L. Fleg, Sonja M. McKinlay,

American Heart Journal

Heart FailureAldosterone Antagonist TrialCardiovascular DiseaseStructural Heart DiseaseCardiovascular PharmacologyPreserved Ejection FractionPharmacotherapyCardiac CareSymptomatic Heart FailureMedicineCardiologyDiastolic FunctionAnesthesiology